On July 23, 2026, Richard J. Simoncic, Chief Operating Officer of Microchip Technology Incorporated (the "Company"), notified the Company that he was resigning from the Company effective August 17, 2026 to become Chief Executive Officer of Menlo Microsystems, Inc., a private company.
On July 23, 2026, Mr. Yuji Ishida, a member of the Board of Directors (the “Board”) of the Company, notified the Board of his resignation as a member of the Board, including his role as member and chair of the Audit Committee of the Board, effective immediately.
Departed
Steven M. Klein
Member Director
Federal Home Loan Bank of New York
Effective
2026-07-20
Filed
July 24, 2026, 10:30 AM ET
Mr. Klein submitted his resignation letter informing the FHLBNY that, effective as of the close of FHLBNY business on July 20, 2026, he would no longer qualify to serve as a Member Director, thereby resigning from the FHLBNY’s Board of Directors as of such date.
Departed
Ty R. Taylor
Director
Federal Home Loan Bank of Chicago
Effective
2026-12-31
Filed
July 24, 2026, 9:57 AM ET
On July 20, 2026, the Federal Home Loan Bank of Chicago (the Bank) received notification from Ty R. Taylor that he is declining to stand for re-election to the Board of Directors in the Bank’s 2026 election of directors.
Departed
James C. Kerr
Executive Vice President and Chief Financial Officer
On July 23, 2026, James C. Kerr, Executive Vice President and Chief Financial Officer, informed The Gorman-Rupp Company (the “Company” or “Gorman-Rupp”) of his decision to retire from the Company.
On July 22, 2026, Dominique Carrel-Billiard notified the Board of Directors (the “Board”) of Victory Capital Holdings, Inc. (the “Company”) of his intent to resign effective July 23, 2026 due to him leaving Amundi.
On July 20, 2026, Terence J. Cryan notified the Company’s Board of Directors of his decision to retire from the Company’s Board of Directors, effective immediately.
Departed
Patrick J. Dawson
Principal Accounting Officer and Corporate Controller
On July 23, 2026, the Company notified Patrick J. Dawson that he will no longer serve as Principal Accounting Officer and Corporate Controller of the Company.
On July 21, 2026, James K. (Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the medical technology industry.
On July 23, 2026, Albertsons Companies, Inc. (the "Company") issued a press release announcing that Sharon McCollam, President and Chief Financial Officer, informed the Company that she has decided to retire later this year.
On July 18, 2026, Prof. Amnon Shashua, President and Chief Executive Officer of Mobileye Global Inc. (the “Company”) informed the Company’s Board of Directors (the “Board”) of his intention to step down as President and Chief Executive Officer upon the appointment of his successor.
On July 16, 2026, Steven Ciardiello notified Shutterstock, Inc. (the “Company”) of his decision to resign as Chief Accounting Officer of the Company, effective August 28 , 2026 following a transition period.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Northfield Bancorp’s directors and executive officers ceased serving as directors and executive officers of Northfield Bancorp.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Northfield Bancorp’s directors and executive officers ceased serving as directors and executive officers of Northfield Bancorp.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Northfield Bancorp’s directors and executive officers ceased serving as directors and executive officers of Northfield Bancorp.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Northfield Bancorp’s directors and executive officers ceased serving as directors and executive officers of Northfield Bancorp.
Departed
J. Ted Nissen
Executive Vice President and Chief Banking Officer of the Company and President and Chief Executive Officer of the Bank
J. Ted Nissen has notified the Company and the Bank of his decision to retire from his positions as Executive Vice President and Chief Banking Officer of the Company and President and Chief Executive Officer of the Bank, effective December 31, 2026.
the Departing Directors submitted irrevocable resignations from the Board and all positions with the Company and its subsidiaries, effective immediately following execution of the Agreement.
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
On July 20, 2026, Dr. Gregory M. Sullivan informed Tonix Pharmaceuticals Holding Corp. (the “Company”) that he will retire from his role as Chief Medical Officer of the Company, effective August 20, 2026.
On July 16, 2026, Kara Wilson notified the Board of Directors (the “Board”) of Paychex, Inc. (the “Company”) of her decision not to stand for re-election at the Company’s annual meeting of stockholders in 2026 (the “Annual Meeting”).
Effective on July 17, 2026, Debra DeFelice no longer serves as Chief Financial Officer (“CFO”), Treasurer, and Executive Vice President of the Company.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
Departed
Matthew A. Hunton
Executive Vice President and President, Kemper Auto
On July 20, 2026, Kemper Corporation (the “Company”) determined that Matthew A. Hunton will depart from his role as Executive Vice President and President, Kemper Auto, effective August 3, 2026.
Departed
Lori Gustafson
Executive Vice President and Chief Brand and Digital Officer
In connection with an internal reorganization, effective July 31, 2026, the position of Executive Vice President and Chief Brand and Digital Officer is being eliminated, and accordingly, Lori Gustafson will separate from the Company.
each of Timothy Lowe and Charles Zeynel notified the Company of his resignation as a member of the Board
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.